SAN DIEGO, Sept. 09, 2015 (GLOBE NEWSWIRE) -- Entra Health today announced the launch of the MyHealthPoint Analyst Portal, a new addition to a growing family of cloud-based telehealth tools for healthcare professionals to monitor and evaluate patient medical data from a regional perspective. MyHealthPoint is an FDA 510K Class II approved online data collection network. The Analyst Portal provides data visualization customized to the requirements of the company’s provider, pharmaceutical and clinical research clients. The portal is an expansion of Entra360, providing easy-to-implement, turnkey solutions for cloud-based analytics and remote patient monitoring.
“The Analyst Portal will be used by over 200 clinical research analysts in 7 separate clinical trials in coming weeks,” said Richard C. Strobridge, CEO of Entra Health. “Current trials include over 500 participating clinics, monitoring patients in 25 countries where analysts monitor and review data collected wirelessly in patients’ homes. Additional applications of the Analyst Portal include enhanced reporting tools to support studies and remote patient management in congestive heart failure (CHF), hypertension, COPD, asthma, and sleep apnea.”
Many customers use Entra Health’s MyGlucoHealth wireless glucose meter where patients take up to seven glucose measurements each day. Blood glucose values are transmitted by Entra Health’s mobile listener app on Android tablets or a wireless hub. Data is stored in the Cloud for review on the Analyst Portal.
The Entra Health Analyst Portal is also engineered to monitor health outcomes for congestive heart failure patients remotely. Wireless activity tracking devices record and transmit levels to the Cloud for access in real-time through the Analyst Portal. In a patient’s home, subjects view activity charts and communicate directly with clinicians using the Entra Connect secure messaging system.
About Entra Health
Entra Health is an international digital health and IT solutions provider that is focused on cloud-based remote patient monitoring, telehealth, data exchange and analytics. Entra Health’s secure Platform-as-a-Service (“PaaS”) remote patient monitoring solutions and devices have regulatory approval in 50 countries. The company is an international leader in wireless biometric data collection. For more information visit: www.entrahealth.com or call 877-458-2646.
MyGlucoHealth™, MyHealthPoint™ and Entra360™ are trademarks of Entra Health Systems.
Media Contact Bruce Ahern, Chief Marketing Officer Entra Health 877-458-2646 x709 email@example.com